Abstract 6615: The smac mimetic Xevinapant increases the efficacy of radiotherapy in triple negative breast cancer but only in the presence of tumor necrosis factor alpha.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Centre Hospitalier de l’Université de Montréal
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148865166
Cites:
Cited by:
Related to:
